NOTCH1 gene amplification promotes expansion of Cancer Associated Fibroblast populations in human skin.
Atul KatarkarGiulia BottoniAndrea ClocchiattiSandro GoruppiPino BordignonFrancesca LazzaroniIlaria GregnaninPaola OstanoVictor NeelGian Paolo DottoPublished in: Nature communications (2020)
Cancer associated fibroblasts (CAFs) are a key component of the tumor microenvironment. Genomic alterations in these cells remain a point of contention. We report that CAFs from skin squamous cell carcinomas (SCCs) display chromosomal alterations, with heterogeneous NOTCH1 gene amplification and overexpression that also occur, to a lesser extent, in dermal fibroblasts of apparently unaffected skin. The fraction of the latter cells harboring NOTCH1 amplification is expanded by chronic UVA exposure, to which CAFs are resistant. The advantage conferred by NOTCH1 amplification and overexpression can be explained by NOTCH1 ability to block the DNA damage response (DDR) and ensuing growth arrest through suppression of ATM-FOXO3a association and downstream signaling cascade. In an orthotopic model of skin SCC, genetic or pharmacological inhibition of NOTCH1 activity suppresses cancer/stromal cells expansion. Here we show that NOTCH1 gene amplification and increased expression in CAFs are an attractive target for stroma-focused anti-cancer intervention.
Keyphrases
- cell proliferation
- copy number
- dna damage response
- nucleic acid
- squamous cell
- induced apoptosis
- genome wide
- wound healing
- randomized controlled trial
- transcription factor
- cell cycle
- soft tissue
- endothelial cells
- cell cycle arrest
- signaling pathway
- skin cancer
- genome wide identification
- dna methylation
- gene expression
- binding protein
- young adults
- extracellular matrix
- drug induced